2025 second_quarter Filing
Q2Expenses
$220K
Method: A
Filed
July 21, 2025
Lobbying Activities
Health IssuesView all
Issues related to drug pricing; Issues related to the drug approval and review process; issues related to operations of the Department of Veterans Affairs including work with clinical trials and research studies; implementation of the Inflation Reduction Act; ORPHAN Cures Act and pharmacy benefit manager legislation; ORPHAN Cures Act language in H.R. 1, One Big Beautiful Bill Act
Contacted:SENATE, Executive Office of the President (EOP), Health & Human Services, Dept of (HHS), HOUSE OF REPRESENTATIVES
Lobbyists (1)
JOHN PAUL HALLIWELL
Foreign Entities
BEONE MEDICINES LTD. (FORMERLY BEIGENE, LTD.)
CH0Ownership: 100%